• Call Us! 786.749.1221

  • NASDAQ: SMFL $0.1756 ( -20.181814% )

Press Release

Smart for Life Announces Letter of Intent to Acquire Premier North American Nutraceuticals Company

Smart for Life Announces Letter of Intent to Acquire Premier North American Nutraceuticals Company 1920 1080 Smart for Life, Inc.

Acquisition is Expected to Add over $15 million of Revenue and to be Accretive to Earnings

Miami, FL – September 29, 2022 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it has executed a non-binding Letter of Intent (LOI) to acquire a premier eCommerce nutraceuticals company with operations in North America.

“We continue to execute on our aggressive M&A strategy, as illustrated by our latest LOI, which would represent our largest acquisition to date,” said A.J. Cervantes, Jr., the Company’s Chairman. “The target business has established a fantastic brand in the health and wellness sector and should be highly synergistic with our existing distribution channels and in-house manufacturing capabilities. Additionally, they achieved over $15 million in sales for the trailing twelve months and have been consistently profitable.”

Darren Minton, CEO of Smart for Life, further noted, “Our management team has stated publicly that we are continuing to implement our high-growth acquisition strategy, and this is another example that we are doing exactly that. Considering the anticipated operating efficiencies to be gained by combining our operations, we expect this transaction will be highly accretive. Moreover, we believe the proposed terms are quite favorable to our shareholders, continuing our track record of acquiring complementary businesses at attractive valuations, especially as we grow toward our stated goal of $100 million in revenue in the next 12 months.”

Smart for Life recently closed its fifth acquisition of Ceautamed Worldwide LLC, owner of the Greens First brand in July. This most recent LOI would represent Smart for Life’s sixth acquisition to date. Completion of the acquisition is subject to a number of conditions including the entry into definitive documentation, successful results from our diligence investigation and obtaining financing to consummate the acquisition.

Mr. Minton concluded, “Despite the unprecedented worldwide financial market conditions, it is our opinion that our proactive acquisition strategy, targeting accretive cash flow positive companies, combined with strategies to enhance organic growth, represents the best path to drive long-term value for shareholders.”

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is a high growth global leader in the Health & Wellness sector, marketing and manufacturing nutritional foods and supplements worldwide. Structured as a publicly held international holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues within the next thirty-six months. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition/Sports Illustrated Nutrition and Ceautamed Worldwide/Greens First. For more information about Smart for Life, please visit: For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Smart For Life to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Smart For Life to Present at the H.C. Wainwright 24th Annual Global Investment Conference 1920 1080 Smart for Life, Inc.

Miami, FL – September 9, 2022 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that Darren Minton, Chief Executive Officer of Smart For Life, will be presenting at the H.C. Wainwright 24th Annual Global Investment Conference which is being held September 12th – 14th, 2022. The event will include virtual participation as well as in-person participation at the Lotte New York Palace Hotel in New York City.

Mr. Minton is scheduled to present on Wednesday, September 14th at 12:30 PM ET. The presentation will be available to registered conference attendees via the conference portal. Additionally, a webcast of the Company’s presentation can be accessed at: https://journey.ct.events/view/4eceed8a-435a-49d0-a9e5-f6bc1e02d1e1 and will be available for replay on the Investor Relations section of Smart for Life’ website at: https://smartforlifecorp.com/investor-center/. Management will also be participating in one-on-one meetings with qualified members of the investment community throughout the conference.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is a high growth global leader in the Health & Wellness sector, marketing and manufacturing nutritional foods and supplements worldwide. Structured as a publicly held international holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues within the next thirty-six months. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition/Sports Illustrated Nutrition and Ceautamed Worldwide/Greens First. For more information about Smart for Life, please visit: For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Smart for Life Names Stuart Benson, JD, as Managing Director of its Newly Formed Smart Acquisition Group

Smart for Life Names Stuart Benson, JD, as Managing Director of its Newly Formed Smart Acquisition Group 1920 1080 Smart for Life, Inc.

Smart Acquisition Group is a Dedicated M&A Team Focused on Accelerating Growth through Acquisitions and other Growth Initiatives

Miami, FL – August 30, 2022 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that Stuart Benson, JD, has been named Managing Director of the Company’s newly formed subsidiary, Smart Acquisition Group, LLC (“SAG”).  SAG is expanding the Company’s M&A growth initiatives through the identification, negotiation, financing and acquisition of companies by Smart for Life.  Mr. Benson most recently served as the Chairman of Ceautamed Worldwide, LLC, the owner of the Greens First line of branded products acquired by Smart for Life on July 29, 2022.

“I met Stuart over a year ago and in the ensuing period of time Smart for Life acquired two companies from Stuart. Most recently, we acquired his company, Ceautamed Worldwide, and previously, we acquired GSP Nutrition, owner of the Sports Illustrated Nutrition brand in November 2021,” said A.J. Cervantes, Jr., the Company’s Chairman.  “I have been continually impressed by the depth of his industry relationships, his knowledge of both securities and corporate law as an attorney, in addition to his financing and business acumen.  I can’t think of a better executive to head up our dedicated acquisition group.”

“Throughout our negotiations this past year, I’ve gotten to know A.J., Darren Minton, the Company’s CEO and Alan Bergman, the Company’s CFO and have developed deep respect for the entire Smart for Life team,” said Mr. Benson.  “The Company is not only aggressively ramping up its M&A activities, it is now targeting significantly larger and more profitable companies.  For these reasons, I’m excited to be leading the SAG team with a primary focus on maximizing value for shareholders.”

About Stuart Benson, JD
Mr. Benson is the Managing Director of Smart Acquisition Group, LLC, the special purpose group dedicated exclusively to the identification, negotiation, financing and acquisition of companies synergistic to Smart for Life’s Buy & Build business model. Mr. Benson is a former principal of Ceautamed Worldwide, LLC, owner of the Greens First line of brand products, Smart for Life’s acquisition completed on July 28, 2022. Mr. Benson was also the Chief Executive Officer of Wellness Watchers Global, LLC. Mr. Benson served as the Chairman and Chief Executive Officer of Custom Food Concepts, Inc. from 1997 to 2001, a company engaged in real estate and franchising. He also served as Executive Vice President of Vital Living Inc. in 2001 and 2002 and served as its Chief Executive Officer since 2005. He served as Chairman, President and Chief Executive Officer of Nathan’s Famous, Inc. and the Great Earth Vitamin Store chain. During his tenure at Nathan’s Famous, the company expanded from 14 units to more than 300, including locations at interstate highways and airports. During Mr. Benson’s tenure at the Great Earth Vitamin Store chain, it grew to approximately 150 full-service vitamin retail stores throughout the U.S. and became the second largest vitamin store in the U.S.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on Health & Wellness. Structured as a publicly held global holding company, the Company is executing a buy-and-build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues within the next thirty-six months. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Smart for Life Announces the “Director’s Forum” – Observations from the Company’s Independent Directors

Smart for Life Announces the “Director’s Forum” – Observations from the Company’s Independent Directors 2560 1327 Smart for Life, Inc.

Current Release Features Ronald S. Altbach, Director and Capital Markets Executive

Miami, FL – August 16, 2022 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, announced the release of the “Director’s Forum,” a newly inaugurated video series featuring the independent members of Smart for Life’s board of directors, their backgrounds and their individual views on the Company and its growth strategy.  This installment highlights Ronald S. Altbach, a prominent capital markets executive and independent director since October 2020.

“Oftentimes, while the board of directors is the governing body of any public company, the directors’ voices are not given prominence,” said A.J. Cervantes, Jr., the Company’s Executive Chairman. “I have known Ron since his early days as a capital markets executive. He has had a lifelong career in the capital markets and has enjoyed significant successes in his career having served in senior leadership positions in a variety of industries, both public and private, with deep experience in merchant banking, as a principal in multiple startups, independent directorships in a number of public companies and significant experience in M&A.”

The Smart for Life “Director’s Forum” video featuring Mr. Altbach can be found here:www.smartforlifecorp.com/ronald-altbach/

About Ronald S. Altbach
Ron Altbach, 73, brings over 40 years as a successful financial services executive with a strong emphasis on M&A, demonstrated repeatedly through his skill and creativity in the formation and successful development of both private and public companies. An experienced venture capitalist and merchant banker, Mr. Altbach is currently a principal in and a Director and Chief Commercial Officer of MPS Infrastructure Inc., a provider of industrial-scale comprehensive energy and potable water solutions internationally, principally in developing countries, most notably the country of Egypt.

Prior to the founding of MPS Infrastructure Inc., Mr. Altbach was a principal in Regeneration Capital Group, a New York-based merchant bank which provided financing and advised on US listings to Chinese middle market companies. He also served as a principal in Cambridge Group Holdings, a financial advisory firm focused on large scale infrastructure projects and structured financing on a global basis.

Mr. Altbach has served in senior leadership positions in a variety of industries, including investment banking, marketing, consumer and luxury products, and media finance. He serves as an independent director on the board of and is a shareholder in Catch Media, a cloud- based technology provider with tens of millions of active users across the globe, and is a principal in Games Marketing, a leading provider of online gaming intellectual property. From 1998 to 2003, he served as founder, Chairman and Chief Executive Officer of Cross Media Marketing Corporation, a publicly held technology-driven direct marketing company.

From 1995 through 1998, Mr. Altbach held the position of Vice Chairman of Rosecliff, Inc., a prominent New York-based merchant bank principally engaged in leveraged buyouts. During the same time period, he served as Chairman of Paul Sebastian, Inc., a Rosecliff portfolio company that marketed its own fragrance brands, as well as licensed brands, to U.S. and international department stores. From 1992 to 1994, Mr. Altbach was President and principal shareholder for Olcott Corporation, which was engaged in the worldwide distribution of luxury products to the mass market as well as through direct sales, television sales and as premiums. From 1983 through 1987, Mr. Altbach conducted media-related financing activities in the entertainment industry; positions included Co-Founder and President of Mediacom Industries, a publicly held film and television finance, production and international distribution company.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on Health & Wellness. Structured as a publicly held global holding company, the Company is executing a buy-and-build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues within the next thirty-six months. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Smart for Life Announces Q2 2022 Financial Results

Smart for Life Announces Q2 2022 Financial Results 1920 1080 Smart for Life, Inc.

Revenue Increases 401.2% Year-Over-Year to $4.3 Million for the Second Quarter of 2022 Due to Successful Acquisition Strategy

Gross Profit Margin Increases to 41.6% Versus 1.1% for the Same Period Last Year

Miami, FL – August 15, 2022 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the health & wellness sector, marketing and manufacturing nutritional foods and supplements worldwide, today provided a business update and reported financial results for the second quarter ended June 30, 2022.

“We continue to generate solid year-over-year growth with revenues increasing more than four-fold to $4.3 million for the second quarter of 2022,” stated Darren Minton, Chief Executive Officer of Smart for Life. “We also achieved a 512.7% year-over-year increase in revenue to $8.7 million for the six months ended June 30, 2022. These strong results reflect our organic growth and the successful implementation of our acquisition strategy.”

“Not included in these results is the fact that we completed the acquisition of Ceautamed Worldwide, a premier nutritional supplement company and owner of the Greens First brand, on July 29, 2022,” remarked Mr. Minton. “This transaction brings solid financials, positive EBITDA, the addition of experienced management, a successful medical distribution channel, migration of substantial contract manufacturing business to our Miami-based manufacturing facility and, most importantly, the addition of the Greens First brand and over 45 SKUs to our growing portfolio of great brands and products. Our mission is to significantly enhance sales by leveraging Ceautamed’s broad distribution medical channel and our own established direct-to-consumer relationships and digital marketing platform. By migrating substantial contract manufacturing business to our Miami-based manufacturing facility, we expect to benefit from meaningful operating efficiencies and cost savings.”

“This is our fifth successful acquisition further validating our “buy and build” growth strategy and our ability to successfully integrate each acquisition into the Smart for Life corporate family,” commented A.J. Cervantes, Jr., Smart for Life’s Executive Chairman.  “Each transaction further validates our ability to acquire cash flow positive companies at attractive multiples, but also our ability to successfully integrate these companies within our organization. With instantly recognizable brands, industry-leading products, loyal customers, and a full range of world-class service offerings, Smart for Life is ideally positioned to bring health & wellness to customers around the world, while remaining laser focused on driving shareholder value.”

“Our proactive acquisition strategy aligns to our previously announced goal of $300 million in revenue within the next thirty-six months,” stated Alan Bergman, Smart for Life’s Chief Financial Officer.  “We believe that the net loss we have generated as an emerging growth company does not fully reflect the benefit of our recent acquisitions. We expect that the consolidation of our operations should result in improved profitability in future quarters as we continue to reduce costs and grow our top-line revenue. In conclusion, we are successfully executing on a carefully orchestrated roll up strategy capitalizing on the fragmented yet rapidly growing nutraceutical market, and believe we are well positioned to drive increased profitability going forward given the scalability of our business model.”

Financial Results
Revenues increased to $4.3 million in Q2 2022 compared to $0.9 million for Q2 2021, an increase of $3.4 million, or 401.2%. The increase was primarily due to the acquisitions of Doctors Scientific Organica, LLC, Nexus Offers, Inc. and GSP Nutrition Inc. that were completed in the third and fourth quarters of 2021. Gross profit increased to $1.8 million in Q2 2022 compared to approximately $9,000 for same period last year, an increase of approximately $1.8 million. Net loss attributable to common shareholders was $3.4 million in Q2 2022 compared to $1.0 million in Q2 2021 primarily due to an increase in general and administrative expenses of $3.1 million and total other expense of $0.7 million.

Revenues increased to $8.7 million for the six months ended June 30, 2022 compared to $1.4 million for the six months ended June 30, 2021, an increase of $7.3 million, or 512.7%, due to the acquisitions completed in 2021. Gross profit increased to $3.3 million for the six months ended June 30, 2022 compared to approximately $30,000 for same period last year, an increase of $3.3 million. Net loss attributable to common shareholders was $20.0 million for the six months ended June 30, 2022 compared to $1.7 million for same period last year, primarily due to the increase in general and administrative expenses of $6.8 million and total other expense of $13.9 million.

The Company reported EBITDA of ($2.0) million in Q2 2022, as compared to EBITDA of ($0.9) million for Q2 2021. For the six months ended June 30, 2022, the Company reported EBITDA of ($5.4) million versus EBITDA of ($1.5) million for the same period last year. The Company defines EBITDA as earnings before interest, taxes and depreciation and amortization.  EBITDA is not a measure of performance calculated in accordance with Generally Accepted Accounting Principles in the United States of America (“GAAP”), and should not be considered in isolation of, or as a substitute for, earnings as an indicator of operating performance or cash flows from operating activities as a measure of liquidity. The Company believes the presentation of EBITDA is relevant and useful by enhancing the readers’ ability to understand the Company’s operating performance. The Company’s management utilizes EBITDA as means to measure performance. The Company’s measurements of EBITDA may not be comparable to similar titled measures reported by other companies. The table below reconciles EBITDA, a non-GAAP measure, to GAAP numbers for net loss for the three and six months ended June 30, 2022 and 2021.

SMFL Q2-2022 Earnings Table Image

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on Health & Wellness. Structured as a publicly held global holding company, the Company is executing a buy-and-build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues within the next thirty-six months. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Smart for Life Releases Online Investor Fact Sheet

Smart for Life Releases Online Investor Fact Sheet 1920 1080 Smart for Life, Inc.

Company Provides Additional Resources for Investors as it Increases its Awareness Initiatives

Miami, FL – August 12, 2022 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the health & wellness sector, marketing and manufacturing nutritional foods and supplements worldwide, announced today the publication of a new online investor fact sheet.

“In line with our efforts to increase transparency and effectively keep the investment community apprised of our recent developments, we are pleased to release our online investor fact sheet,” said Darren Minton, Chief Executive Officer of Smart for Life, Inc. “As stated in our material, the nutraceutical industry is highly fragmented and is experiencing significant growth – expecting to reach $720 billion in size by 2027. As an emerging public company employing a buy-and-build M&A strategy that is focused on vertical and horizontal integration of manufacturing facilities, in addition to expanding our growing portfolio of impressive brands such as Greens First, Smart for Life and Sports Illustrated Nutrition, we believe Smart for Life, Inc. is poised to benefit from the projected rapid expansion of these dynamic industry trends going forward.”

The investor fact sheet provides a clear overview of Smart for Life’s business model and the company’s growth potential, in addition to a great resource for both existing shareholders and prospective investors.

Smart for Life’s investor fact sheet can be viewed and downloaded by navigating to: www.smartforlifecorp.com/ifs.

As the Company expands its awareness initiatives going forward, investors can also find the most current information and material through Smart for Life’s investor portal and can sign up for news alerts at: www.smartforlifecorp.com/investor-center/

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on Health & Wellness. Structured as a publicly held global holding company, the Company is executing a buy-and-build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues within the next thirty-six months. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Smart for Life Announces 171% Increase in Amazon Sales and Largest Prime Day in Its History

Smart for Life Announces 171% Increase in Amazon Sales and Largest Prime Day in Its History 1920 1080 Smart for Life, Inc.

Company Provides Updates on its Amazon Initiatives; Continues its Expansion of Online Presence and Outreach

Miami, FL – August 11, 2022 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the health & wellness sector, marketing and manufacturing nutritional foods and supplements worldwide, announced today that it has achieved a 171% increase in Amazon sales on a year-over-year basis and its largest sales for Amazon Prime Day across all Smart for Life products, more than double its previous best day of Amazon revenue historically.

“We are excited to announce these record results with Amazon, and we are extremely proud of our entire team for making this a reality,” stated Darren Minton, Chief Executive Officer of Smart for Life. “This established growth of our business through online sales, including Amazon Prime, demonstrates our ability to capitalize on meaningful drivers for organic growth. This supports Smart for Life’s vision and commitment to bringing our health and wellness products to new customers in the United States and around the world as we continue expanding awareness of our brand.”

Smart for Life achieved these record Amazon sales for Amazon’s Prime Day initiatives this past month on July 12 -13, 2022.  During the event, Smart for Life sold thousands of protein bars, gummies, cookies and other Health & Wellness products through Amazon, resulting in the highest ever Amazon Prime Day sales for the Company on record.  Smart for Life is also gearing up for Amazon’s annual Fall Deal Event later this year.

“Amazon has been a fantastic sales channel for us as we continue to hit on all cylinders with our omni-channel marketing initiatives,” continued Mr. Minton. “We are progressively growing our sales, both organically, as well as through our buy-and-build M&A strategy.  This includes the domestic market in the United States, as well as in Canada, Mexico and Singapore, where we previously announced that our products were selected by Amazon to be included in their rollout in South-East Asia. We look forward to keeping the market apprised of our milestones and latest developments as they occur.”

Smart for Life’s products, including protein bars, gummies, vitamins, supplements, sports nutrition product and weight management products, can be found on its own website at: www.smartforlife.com, in addition to being sold through Amazon through its Smart for Life Amazon storefront.

Furthermore, certain Smart for Life branded products under the Doctors Scientific Organica brand, as well as the MD Life brand are also listed on Amazon’s storefronts.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on Health & Wellness. Structured as a publicly held global holding company, the Company is executing a buy-and-build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues within the next thirty-six months. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Smart for Life to Host a Conference Call to Discuss Ceautamed Worldwide Acquisition, Positive Developments, and New Strategic Initiatives

Smart for Life to Host a Conference Call to Discuss Ceautamed Worldwide Acquisition, Positive Developments, and New Strategic Initiatives 1920 1080 Smart for Life, Inc.

Miami, FL – August 8, 2022 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the health & wellness sector, marketing and manufacturing nutritional foods and supplements worldwide, today announced it will host a conference call on Wednesday, August 10, 2022, at 4:15 P.M. Eastern Time (ET) to discuss the Ceautamed Worldwide acquisition, positive developments, and new strategic initiatives.

The conference call will be available via telephone by dialing toll-free +1 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and entering access code 354190. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2911/46336 or on the Company’s Investors section of the website: https://smartforlifecorp.com/investor-center/.

A webcast replay will be available on the company’s Investors section of the website through August 10, 2023. A telephone replay of the call will be available approximately one hour following the call, through Wednesday August 24, 2022, and can be accessed by dialing +1 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and entering access code 46336.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on Health & Wellness. Structured as a publicly held global holding company, the Company is executing a buy-and-build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues within the next thirty-six months. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Smart for Life Completes Acquisition of Ceautamed Worldwide the Owner of Greens First

Smart for Life Completes Acquisition of Ceautamed Worldwide the Owner of Greens First 1920 1080 Smart for Life, Inc.

Acquisition Expected to be Highly Synergistic and Accretive

Adds Established Medical Distribution Channel and Expands Product Portfolio

Miami, FL – August 4, 2022 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the health & wellness sector, marketing and manufacturing nutritional foods and supplements worldwide, today announced the completion of its previously announced Ceautamed Worldwide acquisition.

“This is an unequivocal validation of our ‘buy and build’ acquisition strategy, as we execute on our mission to become a dominant global force in the health and wellness sector,” noted A.J. Cervantes, Jr., Executive Chairman of Smart for Life. “This transaction provides numerous benefits to Smart for Life including not only solid financials, including positive EBITDA, but also the addition of experienced management, a successful medical distribution channel, migration of substantial contract manufacturing business to our Miami-based manufacturing facility and, most importantly, the addition of the Greens First brand with over 45 SKUs to our growing portfolio of great brands and products.”

Smart for Life’s acquisition of Ceautamed closed on July 29, 2022 and brings with it the Greens First line of products, which have been sold primarily via medical channels for over 20 years. Ceautamed has historically utilized third-party contract manufacturing that will migrate to Bonne Santé Natural Manufacturing, Smart for Life’s wholly owned state-of-the-art FDA-certified manufacturing facility based in Miami, Florida.

Stuart Benson, Ceautamed’s Founder and Chairman, said, “Ryan Benson, Ceautamed’s Chief Executive Officer, and I have worked proactively with the Smart for Life team to ensure a seamless transition, and we look forward to consolidating Ceautamed’s operations with Smart for Life’s. We have successfully built Ceautamed over the last 20 years and are excited to be part of the team supporting Ceautamed’s next chapter.”

Ryan Benson, Ceautamed’s CEO, remarked, “Over the past decade building our company, our entire team has spent countless hours and has been completely dedicated to the success of Ceautamed’s brands such as Greens First. We are thrilled about our agreement with Smart for Life and we look forward to the long-term future of our business with their support.”

An additional key benefit of the Ceautamed acquisition is leveraging Smart for Life’s considerable direct-to-consumer expertise and cross marketing Greens First products through its existing marketing initiatives on Amazon and other platforms.

“Our entire management team has been diligent in working to identify opportunities that we will now actualize, particularly consolidation and cross marketing benefits of our other products and services,” said Darren Minton, Smart for Life’s Chief Executive Officer. “In addition, this acquisition not only validates our business model but contributes to our previously announced goal of $300 million in revenue within the next several years, while enabling us to achieve significant economies of scale. Despite adverse market conditions, we told our shareholders we would accomplish this acquisition, and we did.”

Alan Bergman, Smart for Life’s Chief Financial Officer, said, “Notwithstanding the worldwide financial market meltdown, high inflation, the Russian-Ukrainian war and the material diminution of market valuations for public companies across the board, we were determined in structuring and securing the necessary financing to successfully complete this transaction. I’m pleased to report that not a single share of stock was sold to accomplish the Ceautamed acquisition.”

Mr. Cervantes added, “We believe it is only a matter of time before the market recognizes the opportunity that Smart for Life represents. Despite adverse conditions that companies of all shapes and sizes are currently experiencing, we believe we will continue to get transactions completed to further our business goals and reach significant organizational milestones which, in turn, can lead to enhanced market valuations.”

Mr. Minton concluded, “It is our opinion that our proactive acquisition strategy, targeting accretive cash flow positive companies, combined with strategies to enhance organic growth, represents the best path to drive long-term value for shareholders.”

A video regarding Mr. Minton’s public statement discussing the Ceautamed acquisition is here: www.smartforlifecorp.com/ceautamed-video/.

About Ceautamed Worldwide
Ceautamed Worldwide, based in Boca Raton, Florida, was formed in 2009 and owns the Greens First line of branded products which have been specifically marketed to the healthcare provider sector. These vitamins and supplements have been sold on a business-to-business basis, direct-to-consumer as well as sold utilizing an international medical distribution company pursuant to a long-term contract. Ceautamed’s Greens First brand also maintains an online presence at: www.greensfirst.com.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on Health & Wellness. Structured as a publicly held global holding company, the Company is executing a buy-and-build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues within the next thirty-six months. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Smart for Life CEO to Participate in the Benzinga All Access Event on July 15th

Smart for Life CEO to Participate in the Benzinga All Access Event on July 15th 1920 1080 Smart for Life, Inc.

Miami, FL – July 13, 2022 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leader in the Health & Wellness sector marketing and manufacturing nutritional supplements and foods worldwide, today announced that Darren Minton, CEO of Smart for Life, will be participating in the Benzinga All Access event taking place on July 15, 2022.

Mr. Minton is scheduled to present on Friday, July 15, 2022, at 9:20 A.M. Eastern Time.

The event will be broadcast live and can be viewed at https://www.youtube.com/watch?v=JuM_q3iRTeM. An archived recording of the presentation will be available on the investor relations section of the Company’s website at https://smartforlifecorp.com/investor-center/.

About Benzinga All Access
Benzinga All Access is a first-of-its-kind show: part interview, part investor presentation. On All Access, Benzinga partners with companies to bring you in-depth one-on-one conversations with executives across a wide range of industries and asset classes. From emerging biotechs, to alternative real estate investment platforms, to everything in between, guests on All Access have one thing in common: they want to tell their story to investors.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a global holding company, the Company is executing a buy-and-build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues within the next thirty-six months. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates four subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Sante Natural Manufacturing and GSP Nutrition. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com